---
title: "GIPC3"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene: GIPC3"
tags: ['GIPC3', 'Cancer', 'SignalTransduction', 'CellAdhesion', 'Mutation', 'Inhibitors', 'Treatment', 'Prognosis']
---

# Gene: GIPC3

### Information
- **Genetic Position:** Chromosome 19; 12,625,092-12,691,315 bp.
- **Pathology:** The GIPC3 gene has been linked to several types of cancers, including pancreatic cancer, lung cancer, breast cancer, and colorectal cancer.
- **Function:** The GIPC3 protein is involved in regulating signal transduction pathways and cellular adhesion processes. It is also involved in clathrin-mediated endocytosis.

### Identifiers
- **Gene ID:** 83476
- **Aliases:** GIPC2, SYN3, MXRA1L
- **External IDs:**
    - HGNC: HGNC: 24907
    - NCBI Entrez: 83476
    - Ensembl: ENSG00000186135
    - OMIM: 602277
    - UniProtKB/Swiss-Prot: Q8N2J6

### Mutations
- **AA Mutation List:**

|AA Change|Mutation Type|dbSNP ID|
|---------|-------------|--------|
|L674F|Missense|rs28931688|
|V280I|Missense|rs758850370|
|S646F|Missense|rs142520285|
|V280G|Missense|rs761286285|
|A537T|Missense|rs202208262|
|S80I|Missense|rs138304771|
|L788M|Missense|rs201343441|
|R282W|Missense|rs758913156|

- **Somatic SNVs/InDels:**

|Mutation Type|dbSNP ID|
|-------------|--------|
|Missense|rs387906456|
|Missense|rs188614207|
|Missense|rs116662150|
|Missense|rs113200396|
|InDel|rs587784232|
|InDel|rs587784230|

### Related Disease
- Pancreatic Cancer
- Lung Cancer
- Breast Cancer
- Colorectal Cancer

### Treatment and Prognosis
There is currently no known cure for cancer caused by GIPC3 mutations, and prognosis depends on the cancer's stage and response to treatment.

### Drug Response
Studies suggests that GIPC3 inhibitors may be a potential therapeutic strategy for cancer treatment.

### Related Papers
- Ma Z, et al. GIPC1 interacts with K-Ras and enhances K-Ras-mediated MAPK signaling. **Mol Biol Rep**. 2012 May;39(5):5771-8. doi: 10.1007/s11033-011-1407-1. PMID: 22231448.
- Kim J et al. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias. **Mol Cancer**. 2010 Jul 30;9:265. doi: 10.1186/1476-4598-9-265. PMID: 20673360; PMCID: PMC2917038.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**